StarTribune.com
fda070109

Home | Lifestyle | Health + Wellness

FDA panel recommends banning two of the most popular painkillers

Last update: June 30, 2009 - 10:44 PM

ADELPHI, MD. - A federal advisory panel voted narrowly Tuesday to recommend a ban on Percocet and Vicodin, two of the most popular prescription painkillers in the world, because of their effects on the liver.

The two drugs combine a narcotic with acetaminophen, the ingredient found in popular over-the-counter products like Tylenol and Excedrin. High doses of acetaminophen are a leading cause of liver damage, and the panel noted that patients who take Percocet and Vicodin for long periods often need higher and higher doses to achieve the same effect.

Acetaminophen is combined with different narcotics in at least seven other prescription drugs, and all of these combination pills will be banned if the Food and Drug Administration heeds the advice of its experts. Vicodin and its generic equivalents alone are prescribed more than 100 million times a year in the United States.

Laureen Cassidy, a spokeswoman for Abbott Laboratories, which makes Vicodin, said, "The FDA will make a final determination, and Abbott will follow the agency's guidance."

The agency is not required to follow the recommendations of its advisory panels, but it usually does.

The panel's 20-17 vote to recommend a ban on the combination drugs was one of 11 it took at a meeting called to advise the FDA on problems arising from the extraordinary popularity of acetaminophen. In 2005, U.S. consumers bought 28 billion doses of products containing the ingredient.

While the medicine is effective in treating headaches and reducing fevers, even recommended doses can cause liver damage in some people. And more than 400 Americans die and 42,000 are hospitalized every year from overdoses.

The committee voted 24-13 to recommend that the FDA reduce the highest allowed dose of acetaminophen in over-the-counter pills like Tylenol to 325 milligrams, from 500.

Recent Health + Wellness stories

Niacin shrinks artery plaque; Merck's Zetia does not and may carry risks, new study finds - June 30, 2009
Niacin shrinks artery plaque; Merck's Zetia does not and may carry risks, new study finds - A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. More

Comment on this story   |   Read all 1 comments   |  Hide reader comments

Subscribe
Shopping + Classifieds
Dog Classified

New Home Wanted

Hundreds of puppies and dogs seeking new homes. Find one now!

Win tickets to The Midnight Movie Society's screening of "Clue" at Red Stag Supperclub.

Vita.mn and DJ Jake Rudh present the first meeting of The Midnight Movie Society at Red Stag Supperclub on Dec. 4, with drinking, dancing and a midnight screening of cult-classic film, "Clue."

See all contests